Sector Chart NGM Biopharmaceuticals, Inc.

Equities

NGM

US62921N1054

Delayed Nasdaq 01:30:00 05/04/2024 am IST 5-day change 1st Jan Change
1.54 USD -1.28% Intraday chart for NGM Biopharmaceuticals, Inc. -.--% +79.28%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
129M - - - - -
118B
106B
23.4B -
21.78B -
18.09B